Company / Cash & Equivalents
DocGo Inc. Cash & Equivalents History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash & Equivalents
$51.0M
FY2025
5-year range
$51.0M / $175.5M
FY2021-FY2025
Trend
-13.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash & Equivalents has declined for 3 consecutive years, from $176M in FY2022 to $51M in FY2025.
Based on SEC 10-K filings.
$51M in FY2025 with a 3-year CAGR of -33.8%.
Declined from $157M to $51M over the past 2 years.
Cash & Equivalents over time
Growth rates
- 3-Year CAGR
- -33.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- DocGo Inc.'s cash & equivalents has declined for 3 consecutive years.
- 3-year CAGR of -33.8%, indicating a declining trend.
- In FY2025, cash & equivalents decreased 13.9% year-over-year.
- Peak cash & equivalents was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 4.19 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash & EquivalentsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $51.0M | -13.9% |
| FY2024 | $59.3M | -62.3% |
| FY2023 | $157.3M | -10.4% |
| FY2022 | $175.5M | +0.0% |
| FY2021 | $175.5M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026